Active substance: Ipidacrini hydrochloridum
Indications: peripheral nervous system diseases; period post organic CNS impairments with movement disorders; complex therapy of demyelinating diseases; memory disorders of various origin; intestinal atony; bulbar paralyses and pareses.
Dose and quantity: 20 mg N50; 5 mg/ml N10; 15 mg/ml N10
Pharmaceutical form: tablets, solution for injections
Product ATC Code: N027AA